Evidence map›Paper›PMID 31263657›Full record

ArticleNanotheranostics2019

Heli Savolainen, Alessia Volpe, Alkystis Phinikaridou, Michael Douek, Gilbert Fruhwirth, Rafael T M de Rosales

Open access · goldAbstract read
In one paragraph

Article in Nanotheranostics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. DNA Nanostructures and DNA-Functionalized Nanoparticles for Cancer Theranostics.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Heli SavolainenDepartment of Imaging Chemistry and Biology, School of Biomedical Engineering & Imaging Sciences, King's College London, London, United Kingdom.
Alessia VolpeDepartment of Imaging Chemistry and Biology, School of Biomedical Engineering & Imaging Sciences, King's College London, London, United Kingdom.
Alkystis PhinikaridouDepartment of Biomedical Engineering, School of Biomedical Engineering & Imaging Sciences, King's College London, London, United Kingdom.
Michael DouekDepartment of Research Oncology, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom.
Gilbert FruhwirthDepartment of Imaging Chemistry and Biology, School of Biomedical Engineering & Imaging Sciences, King's College London, London, United Kingdom.
Rafael T M de RosalesDepartment of Imaging Chemistry and Biology, School of Biomedical Engineering & Imaging Sciences, King's College London, London, United Kingdom.
King's College London · GB

Funding

Cancer Research UK 21153Medical Research Council MC_PC_14105Wellcome Trust
6 · The paper itself

Abstract

Sentinel lymph node biopsy (SLNB) is commonly performed in cancers that metastasise

Indexed as

Magnetic Resonance ImagingPositron-Emission TomographySentinel Lymph Node BiopsyAnimalsBreast NeoplasmsCell Line, TumorDisease Models, AnimalFemaleGallium RadioisotopesHumansHydrodynamicsLymphatic MetastasisLymph NodesMiceParticle SizeRatsGallium-68Gallium Radioisotopes68GaPET-MRIsentinel lymph node biopsySPIO

Identifiers

PMID31263657
PMCPMC6584137
OpenAlexW2953366663

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.